Please ensure Javascript is enabled for purposes of website accessibility

Why PLx Pharma Blasted Nearly 20% Higher Today

By Eric Volkman - Jul 20, 2021 at 3:20PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is on a roll, scoring its second major retail distribution deal in as many weeks.

What happened

PLx Pharma (PLXP -36.68%) was a monster outperformer on Tuesday; its shares were up by almost 20% in late afternoon trading. That was hardly surprising, given the company's excellent news released after market close the previous day.

So what

Monday night, PLx Pharma announced that its leading product, Vazalore, will be offered in more than 8,000 Walgreens Boots Alliance (WBA 1.30%) stores, beginning next month.

Adult and child looking at the shelves of a pharmacy.

Image source: Getty Images.

The big pharmacy chain will offer all three stock keeping units (SKUs) of Vazalore. The over-the-counter drug comes in 81-milligram capsules in 12- and 30-count containers, and a 325-milligram version is available in a 30-count package.

Approved by the Food and Drug Administration (FDA), Vazalore safely delivers liquid aspirin through the stomach to treat pain in the gastrointestinal system. PLx Pharma is not shy to point out that it is the first and (so far) only liquid aspirin capsule to have received the nod from the regulator.

This is the second high-profile Vazalore retail arrangement PLx Pharma has announced in as many weeks. Earlier in the month, it signed a deal with Walmart for all three SKUs to be stocked at over 4,500 of that company's outlets.

Now what

With these two arrangements, it's clear that PLx Pharma has a winning product that has top chain store operators seeing dollar signs. While Walmart- and Walgreens-sized deals are few and far between, we can nevertheless expect to soon see Vazalore on the shelves of more pharmacies, and perhaps even other types of retailers.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

PLx Pharma Inc. Stock Quote
PLx Pharma Inc.
PLXP
$1.64 (-36.68%) $0.95
Walgreens Boots Alliance, Inc. Stock Quote
Walgreens Boots Alliance, Inc.
WBA
$40.59 (1.30%) $0.52

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
400%
 
S&P 500 Returns
128%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/14/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.